Merck & Company Pre-earnings Analysis As market valuations get stretched to record highs, investors are searching for “undercover” opportunities to take on. The pharmaceutical space is of those “undercover” opportunities that has lagged far behind the market rally, potentially being a good place for investors with a longer time horizon to park capital. Before getting into the upside, let’s talk about why pharmaceuticals are trading far behind the market:The most prominent reason pharmaceutical stocks aren’t catching rhythm is because of the ongoing regulatory and pricing pressure from the current administration. In the U.S., there’s a strong policy rhetoric around forcing drug price reductions, creating margin risk for investors. And beyond pricing, tariffs on pharmaceutical imports is also a threat. For...
Chipotle Pre-earnings Analysis Chipotle stock has been beaten down over the past twelve months as the company suffers from slowing growth, especially in same store sales in North America. From the years 2022-2024, Chipotle managed to report consistent revenue growth around 14%, but Q1 and Q2 of 2025 slowed to just 6.4% and 3.04% growth, leading investors to scale back on their positions and leaving the stock in “free fall,” especially after the last report, when net income also dipped, falling 4.3% YoY. Although Chipotle remains a dominant force in the fast casual dining segment, its near term outlook is complicated by a maturing U.S. market. After years of price hikes, many consumers are turning to home cooked meals or...
Taiwan Semiconductor Manufacturing Company A.K.A TSMC ($TSM) Pre-earnings Analysis All eyes are on the semiconductor industry this week as TSMC, the world’s most advanced chipmaker, gets ready to report quarterly earnings. As the key supplier behind Nvidia’s and AMD’s cutting edge chips, TSMC’s results often set the tone for the entire tech sector, and could offer insight into where AI-driven demand is headed next. In case you don’t know, TSMC produces roughly 60% of the world’s total semiconductor chips and over 90% of global advanced chips. Yes, companies like Apple, Nvidia, AMD, and Qualcomm design their own chips, but it’s TSMC that actually manufactures them. That makes TSMC’s earnings crucial, as they serve as a real time reflection of global...
JP Morgan Chase (JPM) Pre-earnings Analysis With $4.6 trillion in assets under management (AUM), JP Morgan has grown to become a financial powerhouse in the United States and is spreading is reach across the globe. It is now the largest bank in the U.S. by AUM, covering consumer banking, commercial banking, investment banking, asset and wealth management. They serve individual clients, corporations, and even governments worldwide. Trading near record highs, investors are nervously excited to see if JP Morgan can exceed its expectations of $45.28 billion in quarterly revenue, which would mark 6.2% growth from its last report. The stock is close to hitting the $1 trillion market cap, and good earnings can propel them towards that target in the...
Celsius Holdings (CELH) Analysis Investors who missed out on Monster Beverage as an investment may have a chance at redemption through Celsius, which is quickly becoming a go-to energy drink at retailers, convenience stores, and other sales channels. The company’s original product “Celsius,” marketed as a “calorie burning beverage” designed to boost metabolism thanks to natural ingredients, positioned it as a healthier, fitness oriented alternative to names like RedBull and Monster. This push coincided with a period where consumers were gravitating towards healthier options, allowing the company to grow from $75 million in annual revenue in 2019 to more than $1.3B in 2024. This massive revenue growth was recognized by investors, allowing the stock to rally significantly during that period,...
